No definition available.
Multiple myeloma and malignant plasma cell neoplasms
C3_MULTIPLE_MYELOMA_PLASMA_CELL
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2875 |
4. Check minimum number of eventsNone |
2875 |
5. Include endpointsNone |
2875 |
6. Filter based on genotype QC (FinnGen only) |
1830 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Myeloma multiplex et neoplasmata maligna plasmacytorum
Similar endpoints
↥List of similar endpoints to
Multiple myeloma and malignant plasma cell neoplasms
based on the number of shared cases.
Similar with more cases:
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1830 | 790 | 1040 |
| Unadjusted period prevalence (%) | 0.39 | 0.28 | 0.48 |
| Median age at first event (years) | 70.02 | 68.94 | 70.83 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1896
- Matched controls
- 18960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.1
312.5
305
254
ZX112
NOMESCO Finland
Subcutaneous
20.6
307.7
305
175
A04AA01
ATC
ondansetron; systemic, rectal
10.9
307.7
671
910
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
6707.8
307.7
1039
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
335.4
307.7
309
11
L03AA02
ATC
filgrastim; parenteral
32.7
307.7
581
253
J05AB01
ATC
aciclovir; systemic
7.1
307.7
1004
2597
329
Kela drug reimbursment
Lenalidomide
+∞
307.7
638
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.6
307.7
485
544
B03XA02
ATC
darbepoetin alfa; parenteral
16.7
307.7
304
214
H02AB02
ATC
dexamethasone; systemic
19.4
307.7
1138
1363
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
166.8
307.7
208
14
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
41.9
307.7
350
102
153
Kela drug reimbursment
Lenalidomid
+∞
307.7
836
*
AA1AA
NOMESCO Finland
Head X-ray examination
60.6
307.7
262
50
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
98.5
307.7
1340
453
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
31.0
307.7
254
94
XW000
NOMESCO Finland
Bone marrow biopsy
38.7
307.7
906
438
C90.0
ICD-10 Finland
Multiple myeloma
+∞
307.7
1701
*
M04AA01
ATC
allopurinol; systemic
7.9
307.7
936
2087
L04AX04
ATC
lenalidomide; oral
+∞
307.7
802
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
484.3
297.9
290
7
WW300
NOMESCO Finland
Transfer of autologic stem cells
378.6
291.6
287
9
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
13.4
279.6
280
242
WW500
NOMESCO Finland
Blood transfusion
9.4
257.6
338
427
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
24.3
252.4
183
83
WF049
NOMESCO Finland
Radiotherapy of metastasis
9.7
251.1
321
392
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
24.6
248.3
179
80
L01AA03
ATC
melphalan; systemic
1338.9
246.4
235
*
ZX108
NOMESCO Finland
Inhalation
39.0
244.5
151
42
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.8
239.0
1237
5346
M05BA02
ATC
clodronic acid; systemic
41.7
235.9
143
37
393
Kela drug reimbursment
Pomalidomide
+∞
231.1
217
*
N02AA05
ATC
oxycodone; systemic
4.5
225.9
879
3047
L04AX06
ATC
pomalidomide; oral
+∞
221.3
208
*
1507
Kela drug reimbursment
Pomalidomide
+∞
219.1
206
*
B74
ICPC
Malignant neoplasm blood other
111.1
204.8
105
10
ZX120
NOMESCO Finland
Intravenous
5.5
204.3
477
1088
B03XA01
ATC
erythropoietin; parenteral
24.6
203.5
146
64
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
80.1
198.6
106
14
212
Kela drug reimbursment
Gout
11.0
186.8
209
211
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.8
186.7
282
416
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.1
180.4
359
703
R50.9
ICD-10 Finland
Fever, unspecified
4.3
174.2
608
1892
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
8.6
170.1
232
303
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
167.8
556
1660
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
164.0
155
*
J05AB11
ATC
valaciclovir; oral
4.3
162.9
548
1651
L01AA01
ATC
cyclophosphamide; systemic
33.7
145.1
93
29
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
138.2
131
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
1393.8
135.1
130
*
WW200
NOMESCO Finland
Immunization
9.4
134.9
167
192
WW409
NOMESCO Finland
Other aferesis
207.5
131.5
135
7
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
20.4
128.5
99
51
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.3
119.3
149
173
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.9
117.9
411
1245
L01FC01
ATC
daratumumab; parenteral
+∞
116.9
111
*
M05BX04
ATC
denosumab; parenteral
4.5
116.3
321
818
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.0
112.1
368
1066
JN4AD
NOMESCO Finland
Body CT examination
3.5
111.6
475
1640
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
24.6
109.6
78
33
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
11.1
109.5
119
114
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.8
104.6
171
271
398
Kela drug reimbursment
Ixazomib
+∞
102.0
97
*
1XX32, ,
NOMESCO Finland
1031.6
101.1
98
*
B01AB05
ATC
enoxaparin; parenteral
2.8
100.0
901
4694
3060, ,
Kela drug reimbursment
+∞
97.8
93
*
1534, ,
Kela drug reimbursment
+∞
96.7
92
*
1505
Kela drug reimbursment
Ixazomib
+∞
96.7
92
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
95.3
853
4402
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.1
94.0
215
467
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
7.2
93.7
144
213
D64.9
ICD-10 Finland
Anaemia, unspecified
3.2
92.7
457
1708
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
12.5
91.4
91
76
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.5
88.7
234
571
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
10.2
88.1
101
104
L04AX02
ATC
thalidomide; oral
453.1
87.9
87
*
E85.9
ICD-10 Finland
Amyloidosis, unspecified
44.5
87.3
52
12
J01MA12
ATC
levofloxacin; systemic
2.8
86.7
595
2659
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
20.1
85.4
66
34
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
27.2
84.6
58
22
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
83.2
1261
8193
WF004
NOMESCO Finland
Palliative radiotherapy
6.6
81.7
137
222
E83.50
ICD-10 Finland
Hypercalcemia
9.4
81.6
99
110
TK800
NOMESCO Finland
Hemodialysis
7.4
80.7
120
171
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.2
80.2
144
250
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
80.1
576
2622
5BA08, ,
NOMESCO Finland
16.9
79.9
67
41
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
79.7
76
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
10.7
78.7
87
85
WW402
NOMESCO Finland
Leucoferesis
+∞
78.7
75
*
GA5AA
NOMESCO Finland
Rib X-ray examination
21.0
77.8
59
29
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
77.6
74
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.0
76.2
176
384
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
30.2
75.5
50
17
B01AB10
ATC
tinzaparin; parenteral
3.1
73.9
361
1328
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.2
73.0
214
563
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.1
70.7
209
553
WZC00
NOMESCO Finland
Treatment plan or consultation
2.4
70.6
866
4989
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
9.8
69.9
82
87
J01MA14
ATC
moxifloxacin; systemic
3.3
69.4
304
1046
127
Kela drug reimbursment
Transplant complication
9.1
68.9
86
99
C03CA01
ATC
furosemide; systemic
2.3
68.2
960
5838
Z51.5
ICD-10 Finland
Palliative care
3.0
66.6
358
1384
A05AA02
ATC
ursodeoxycholic acid; oral
10.0
64.0
74
77
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
+∞
63.9
61
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
63.2
407
1728
D70.89
ICD-10 Finland
Neutropenic splenomegaly
8.7
62.6
80
95
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
22.4
62.4
46
21
Z52.89
ICD-10 Finland
Donor of other organ or tissue
323.2
61.7
62
*
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
317.6
60.7
61
*
L01XG03
ATC
ixazomib; oral
+∞
59.7
57
*
A02BC02
ATC
pantoprazole; systemic
2.4
57.2
1472
11133
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
55.5
158
405
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
15.2
52.1
46
31
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
5.1
50.9
109
222
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
10.3
50.6
57
57
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.5
50.5
128
300
WVA20
NOMESCO Finland
Medicine administration
4.8
50.0
118
261
H02AB09
ATC
hydrocortisone; systemic
5.4
48.4
97
186
NF3AA
NOMESCO Finland
Femur X-ray examination
4.9
47.8
108
230
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
10.3
47.0
53
53
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
46.6
837
5350
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
13.2
46.1
44
34
XX3DW
NOMESCO Finland
Time consuming IT work
2.5
43.3
312
1380
306
Kela drug reimbursment
Erythropoietin and darbepoetin
17.8
42.9
35
20
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
+∞
42.9
41
*
NB6AA
NOMESCO Finland
Humerus X-ray examination
4.7
42.4
101
225
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
41.9
522
2901
L01XX50
ATC
[U] ixazomib
+∞
41.8
40
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
7.1
41.7
63
91
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.6
41.5
68
107
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
54.7
40.6
48
9
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
40.3
549
3146
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
16.5
40.1
34
21
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
40.1
321
1486
WZC15, ,
NOMESCO Finland
8.6
39.6
51
61
A79
ICPC
Malignancy NOS
5.4
39.2
79
152
E85.89
ICD-10 Finland
Other amyloidosis
204.2
39.0
40
*
H02AB06
ATC
prednisolone; systemic
1.9
38.8
1017
7227
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
+∞
37.6
36
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.0
36.8
107
278
A06AD11
ATC
lactulose; oral
2.1
36.2
435
2368
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
12.2
36.0
36
30
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
35.7
205
807
N17.8
ICD-10 Finland
Other acute renal failure
5.6
35.2
68
126
GD1AD
NOMESCO Finland
Thorax CT examination
2.7
34.3
197
776
A11CC03
ATC
alfacalcidol; systemic
4.2
33.6
91
224
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.9
33.5
103
278
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.3
33.4
88
212
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
12.5
32.4
32
26
N18.8
ICD-10 Finland
Other chronic renal failure
3.9
31.4
96
258
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
31.2
134
449
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.8
31.0
97
265
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.5
30.9
108
318
ED1AA
NOMESCO Finland
Mandibular X-ray examination
9.9
30.4
35
36
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.1
30.4
53
89
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
30.3
29
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
9.6
29.8
35
37
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
5.4
29.7
59
112
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
29.7
217
958
N03AX16
ATC
[U] pregabalin
1.9
29.3
500
3043
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
8.9
29.0
36
41
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
28.9
947
6960
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.3
28.9
59
115
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
8.6
28.8
37
44
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
28.3
309
1608
1CX01, ,
NOMESCO Finland
55.9
28.2
33
6
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
28.2
260
1267
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
27.6
256
1249
L04AD01
ATC
ciclosporin; systemic
5.3
27.5
56
109
N05CF01
ATC
zopiclone; oral
1.7
27.5
699
4773
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
6.9
27.2
42
62
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.6
27.2
171
703
WD335, ,
NOMESCO Finland
+∞
27.1
26
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
27.1
26
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
27.0
573
3712
9731/3-C42.1
ICD-O-3
Plasmacytoma, NOS, of bone marrow
142.0
26.7
28
*
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
7.4
26.3
38
52
NB4AA
NOMESCO Finland
Scapula X-ray examination
9.5
26.2
31
33
N02AX02
ATC
tramadol; systemic, rectal
1.7
26.2
889
6536
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
+∞
26.1
25
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
45.0
25.6
31
7
EBA10
NOMESCO Finland
Operative extraction of tooth
2.3
25.4
202
923
L03AA13
ATC
pegfilgrastim; parenteral
3.0
25.4
116
403
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
25.3
199
905
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.5
25.3
49
91
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.9
25.1
55
114
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.9
25.1
56
118
JN4BD
NOMESCO Finland
Extensive body CT
2.1
25.0
272
1410
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.7
24.8
57
123
ZXD05
NOMESCO Finland
Urgent procedure
1.7
24.6
592
3953
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.3
24.5
93
289
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
28.0
24.5
33
12
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
29.6
24.1
32
11
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.6
23.9
80
229
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.3
23.4
89
277
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
6.9
23.4
36
53
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.7
23.1
73
201
5BA03, ,
NOMESCO Finland
+∞
23.0
22
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
22.9
702
4976
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
6.2
22.9
39
64
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
121.5
22.6
24
*
WF099
NOMESCO Finland
Other radiotherapy
7.6
22.5
32
43
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
22.4
657
4600
NA2AD
NOMESCO Finland
Thoracic spine CT examination
6.5
22.2
36
56
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
22.1
500
3267
N19
ICD-10 Finland
Unspecified kidney failure
2.6
21.5
126
499
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
17.7
21.3
33
19
SPAT1088
SPAT
Blood transfusion
7.6
21.2
30
40
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
20.5
235
1237
A07AA02
ATC
nystatin; oral
2.4
20.4
153
680
R80
ICD-10 Finland
Isolated proteinuria
6.4
20.1
33
52
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.0
20.0
43
88
WZC30
NOMESCO Finland
Teaching
1.8
19.5
358
2194
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
7.5
19.5
28
38
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.4
19.4
71
216
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
19.3
625
4450
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
55.6
18.9
22
*
L03AB05
ATC
interferon alfa-2b; parenteral
15.0
18.9
31
21
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
18.8
18
*
A07AA09
ATC
vancomycin; oral
4.2
18.7
50
122
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.3
18.7
153
707
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
18.6
320
1923
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.0
18.3
83
287
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.5
18.3
44
99
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.8
18.2
282
1641
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.3
18.1
69
215
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
6.8
17.9
28
42
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
17.7
17
*
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.1
17.7
73
239
A06AH03
ATC
naloxegol; oral
3.8
17.7
53
141
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.2
17.2
35
68
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.4
17.2
62
187
J02AC03
ATC
voriconazole; systemic
16.1
17.0
27
17
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
19.5
16.9
25
13
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
63.9
16.8
19
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
63.9
16.8
19
*
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
16.7
125
555
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
35.4
16.7
21
6
ZX112, ,
SPAT
6.0
16.5
29
49
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.6
16.5
97
385
SPAT1255
SPAT
Intravenous administration of medicine
2.1
16.5
162
804
ECB20
NOMESCO Finland
Oral alveoplasty
4.6
16.4
39
87
ZY010
NOMESCO Finland
Hospital outpatient
2.7
16.3
88
335
3025
Kela drug reimbursment
Calcium carbonate
6.8
16.2
25
37
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.6
16.1
54
155
N02BF02
ATC
pregabalin; oral
2.2
16.1
140
662
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.5
16.0
54
156
A12AA04
ATC
calcium carbonate; oral
3.8
16.0
48
128
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
15.9
142
680
3XA02, ,
NOMESCO Finland
60.5
15.8
18
*
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
60.5
15.8
18
*
ZX080
NOMESCO Finland
Image guided radiotherapy
3.2
15.5
61
194
B73
ICPC
Leukaemia
22.2
15.5
22
10
L71
ICPC
Malignant neoplasm musculoskeletal
38.4
15.4
19
5
H26.3
ICD-10 Finland
Drug-induced cataract
6.5
15.4
25
39
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
15.3
122
557
Z3231
NOMESCO Finland
Registered nurse
1.6
15.2
528
3778
L01BB05
ATC
fludarabine; systemic
23.6
15.1
21
9
1AA01, ,
NOMESCO Finland
45.4
15.1
18
*
A28
ICPC
Limited function/disability NOS
1.6
15.0
458
3182
J01CA04
ATC
amoxicillin; systemic
1.5
14.9
1416
12431
D64.8
ICD-10 Finland
Other specified anaemias
3.2
14.9
59
189
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
14.8
191
1044
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
16.6
14.8
23
14
L04AA06
ATC
mycophenolic acid; systemic
3.7
14.7
47
131
B02.9
ICD-10 Finland
Zoster without complication
2.0
14.6
166
869
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.2
14.4
57
182
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.8
14.3
70
253
6BA02, ,
NOMESCO Finland
19.3
14.2
21
11
H02AB07
ATC
prednisone; oral
1.7
14.2
279
1733
A10AC01
ATC
insulin (human); parenteral
2.0
14.1
166
880
L04AA01
ATC
[U] ciclosporin
4.5
14.0
34
77
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
6.7
14.0
22
33
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
5.5
14.0
27
50
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
3.1
13.9
58
192
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
13.8
339
2230
J12.8
ICD-10 Finland
Other viral pneumonia
4.8
13.8
31
66
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.7
13.6
75
289
JN4BG
NOMESCO Finland
Body MRI with high intensity magnet
+∞
13.6
13
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
13.6
421
2929
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.5
13.5
26
48
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.6
13.3
75
292
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
40.4
13.2
16
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.7
13.1
30
65
E83.51
ICD-10 Finland
Hypocalcemia
6.0
13.1
23
39
JN6AD
NOMESCO Finland
CT of torso and neck
3.4
13.0
47
142
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
16.8
13.0
20
12
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
13.0
421
2954
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.0
12.9
36
91
1XC02, ,
NOMESCO Finland
5.2
12.7
26
51
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
+∞
12.5
12
*
20399
ICD-8 Finland
Multiple myeloma
+∞
12.5
12
*
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
12.5
12
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.1
12.4
127
641
YX9AW, ,
NOMESCO Finland
5.4
12.3
24
45
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
14.4
12.3
20
14
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
5.0
12.2
26
53
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
6.1
12.1
21
35
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
12.1
267
1708
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.3
12.0
91
407
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
21.4
12.0
17
8
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
10.1
12.0
23
23
A41.8
ICD-10 Finland
Other specified sepsis
2.8
12.0
58
209
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
3.3
11.9
45
140
C10AA07
ATC
rosuvastatin; oral
0.6
11.9
346
4872
N18.0
ICD-10 Finland
End-stage renal disease
4.0
11.9
33
83
B03BA03
ATC
hydroxocobalamin; parenteral
2.0
11.8
137
722
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.5
11.8
71
286
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
14.7
11.8
19
13
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
4.5
11.7
28
63
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
11.6
116
580
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
11.6
127
657
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
5.3
11.5
23
44
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.2
11.5
30
72
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
11.5
11
*
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
11.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.8
11.4
56
203
H02AB04
ATC
methylprednisolone; systemic
1.6
11.4
265
1716
R06AE07
ATC
cetirizine; oral
1.4
11.4
675
5313
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.1
11.3
46
150
TGC00
NOMESCO Finland
Bronchial lavation
2.6
11.3
66
262
A10AB05
ATC
insulin aspart; parenteral
1.8
11.3
160
902
A02BC01
ATC
omeprazole; systemic
1.5
11.2
510
3820
N02BE01
ATC
paracetamol; systemic, rectal
1.6
11.2
1644
15197
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.7
11.1
35
97
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
11.1
350
2434
L01AA02
ATC
chlorambucil; oral
8.6
11.0
23
27
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
9.3
11.0
22
24
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.7
10.9
57
214
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
9.6
10.7
21
22
J12.2
ICD-10 Finland
Parainfluenza virus pneumonia
28.2
10.7
14
5
ZXE00
NOMESCO Finland
One hour or less
1.4
10.7
673
5339
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
10.6
718
5763
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
10.6
150
845
JN4CD
NOMESCO Finland
Very extensive body CT
2.2
10.5
89
417
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
10.1
10.5
20
20
NAR00
NOMESCO Finland
Complete excision of tumour of bone or cartilage of spine, unspecified
+∞
10.4
10
*
9733/3-C42.1
ICD-O-3
Plasma cell leukemia of bone marrow
+∞
10.4
10
*
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
10.4
211
1318
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.1
10.2
93
449
V03AE01
ATC
polystyrene sulfonate; oral
3.2
10.0
39
124
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
10.1
10.0
19
19
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
14.7
10.0
16
11
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.7
10.0
31
85
372
Kela drug reimbursment
Idelalisib
40.3
10.0
12
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
9.9
460
3450
WX720
NOMESCO Finland
Own respiration
2.0
9.8
99
497
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
4.0
9.8
27
68
NB3AA
NOMESCO Finland
Clavicle X-ray examination
3.3
9.7
35
106
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
9.7
318
2225
A03
ICPC
Fever
1.6
9.6
233
1521
M54.5
ICD-10 Finland
Low back pain
1.4
9.6
588
4622
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.0
9.6
41
138
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.5
751
6155
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
9.4
360
2596
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.1
9.4
39
129
L01XE27
ATC
[U] ibrutinib
17.6
9.4
14
8
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
9.4
207
3120
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
8.1
9.3
20
25
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
4.9
9.3
20
41
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.9
9.3
42
146
N03AX12
ATC
[U] gabapentin; oral
1.5
9.2
290
2008
M54.6
ICD-10 Finland
Pain in thoracic spine
1.9
9.2
115
622
B99
ICPC
Blood/lymph/spleen disease other
7.3
9.2
21
29
R93.7
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
13.7
9.2
15
11
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
4.3
9.1
23
54
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
9.1
193
1220
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
8.3
9.1
19
23
C10AC01
ATC
colestyramine; oral
2.6
9.0
52
206
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.1
9.0
24
59
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
4.1
9.0
24
59
L01BB02
ATC
mercaptopurine; oral
4.4
8.9
22
51
ZX100
NOMESCO Finland
Oral
3.0
8.9
37
123
TK810
NOMESCO Finland
Hemofiltration
4.9
8.8
19
39
390
Kela drug reimbursment
Ibrutinib
10.7
8.8
16
15
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
8.8
428
3228
R06.0
ICD-10 Finland
Dyspnoea
1.4
8.8
538
4220
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
7.2
8.7
20
28
B34.9
ICD-10 Finland
Viral infection, unspecified
2.7
8.7
44
163
W0X00
NOMESCO Finland
Estimation of continuous need for medical therapy
14.1
8.7
14
10
R11
ICD-10 Finland
Nausea and vomiting
1.7
8.7
160
974
S42.3
ICD-10 Finland
Fracture of shaft of humerus
3.1
8.5
34
110
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
10.1
8.5
16
16
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
20.1
8.5
12
6
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
8.4
304
2165
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.3
8.4
21
49
GA5DA
NOMESCO Finland
Bilateral rib X-ray exmaination
+∞
8.3
8
*
9731/3-C41.4
ICD-O-3
Plasmacytoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
8.3
8
*
1XX45, ,
NOMESCO Finland
+∞
8.3
8
*
1512
Kela drug reimbursment
Ibrutinib
10.8
8.3
15
14
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
10.8
8.3
15
14
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
8.2
206
1358
J02AC01
ATC
fluconazole; systemic
1.4
8.2
535
4234
WPA13
NOMESCO Finland
Palliative consultation
4.8
8.1
18
38
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.8
8.1
110
613
L01XX47
ATC
[U] idelalisib
33.5
8.1
10
*
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
11.7
8.1
14
12
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.6
8.0
45
176
TPH04, ,
SPAT
3.3
7.8
28
85
J01FF01
ATC
clindamycin; systemic
1.4
7.8
458
3558
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
45.2
7.7
9
*
L04AD02
ATC
tacrolimus; systemic
3.9
7.7
22
57
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.9
7.7
22
57
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
7.7
316
2306
WF002
NOMESCO Finland
Radical radiotherapy
1.8
7.7
124
728
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.3
7.7
56
248
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
25.1
7.6
10
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.2
7.5
29
92
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
10.1
7.5
14
14
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.1
7.5
68
329
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
7.5
138
840
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.0
7.5
79
405
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
7.4
309
2258
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
3.6
7.4
24
68
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
80.4
7.4
8
*
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
3.1
7.3
30
99
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.8
7.3
34
121
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
7.3
227
1568
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.3
719
6024
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
15.8
7.2
11
7
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.7
7.2
36
133
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.7
7.2
22
60
J20.4
ICD-10 Finland
Acute bronchitis due to parainfluenza virus
20.1
7.1
10
5
J01DB01
ATC
cefalexin; oral
1.3
7.1
1418
13043
399
Kela drug reimbursment
Venetoclax
7.9
7.1
15
19
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
7.1
216
1484
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.3
7.1
52
231
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
6.0
7.1
18
30
K10.25
ICD-10 Finland
Sequences of jawbones
5.6
7.1
19
34
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
6.3
6.9
17
27
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.9
6.9
82
438
NB6AD
NOMESCO Finland
Upper arm CT
13.8
6.9
11
8
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
13.8
6.9
11
8
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
6.9
143
900
L01XX52
ATC
venetoclax; oral
8.3
6.8
14
17
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.3
6.8
49
216
DMW00
NOMESCO Finland
Intubation of maxillary antrum
11.0
6.8
12
11
B01.9
ICD-10 Finland
Varicella without complication
9.3
6.8
13
14
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.0
6.8
67
336
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.9
6.8
80
427
XX1VW
NOMESCO Finland
Written report from radiologist
3.7
6.8
21
58
5AB14, ,
NOMESCO Finland
16.7
6.7
10
6
N06DX01
ATC
memantine; oral
0.5
6.7
70
1293
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
7.2
6.7
15
21
Z51.0
ICD-10 Finland
Radiotherapy session
2.7
6.6
34
128
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
3.4
6.6
23
69
L03AA04, ,
ATC
8.7
6.5
13
15
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.9
6.5
74
390
R4190
NOMESCO Finland
Nutritional therapy
2.1
6.5
62
307
R4110
NOMESCO Finland
Physiotherapy
1.3
6.4
489
3935
ZXY12
NOMESCO Finland
Trainee nurse, supervised
70.1
6.4
7
*
L03AA10
ATC
lenograstim; parenteral
70.1
6.4
7
*
C10AX09
ATC
ezetimibe; oral
0.7
6.4
166
2431
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
7.4
6.4
14
19
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.3
6.4
45
197
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.1
6.4
26
86
K10.21
ICD-10 Finland
Osteoradionecrosis of jaw (acute)(chronic)(suppurative)
8.2
6.3
13
16
J04BA02
ATC
dapsone; oral
5.5
6.3
17
31
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.5
6.3
38
155
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.7
6.3
315
4091
N06DA02
ATC
donepezil; oral
0.5
6.3
48
981
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
6.3
6
*
M907, C6488,
ICD-10 Finland
+∞
6.3
6
*
9731/3-C41.9
ICD-O-3
Plasmacytoma, NOS, of bone, NOS
+∞
6.3
6
*
B01.8
ICD-10 Finland
Varicella with other complications
+∞
6.3
6
*
A32.7
ICD-10 Finland
Listerial sepsis
26.8
6.2
8
*
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
26.8
6.2
8
*
D69.5
ICD-10 Finland
Secondary thrombocytopenia
7.0
6.2
14
20
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
6.2
1143
10291
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.7
6.2
19
52
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.1
6.2
24
77
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.2
414
3270
C08CA01
ATC
amlodipine; oral
1.3
6.2
789
6795
S72.3
ICD-10 Finland
Fracture of shaft of femur
3.3
6.1
22
67
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.0
6.1
26
88
B82
ICPC
Anaemia other/unspecified
2.0
6.1
67
349
WPB10
NOMESCO Finland
Making a convalescent care decision
4.1
6.1
16
39
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
12.6
6.1
10
8
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
6.7
6.0
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1230
723
46.58
307.65
21.6
1.7
242.52
45.74
mg/l
2.57
1156
617
686
768
13.43
307.65
18.4
1.6
10.96
10.43
g/l
0.68
652
672
930
866
20.12
307.65
16.3
1.6
6.97
7.50
g/l
12.27
915
774
577
624
12.85
307.65
18.0
1.6
0.00
0.00
g/l
0.93
443
548
248
22
129.54
307.65
1.2
1.7
—
—
—
0
0
748
212
57.62
307.65
4.4
2.0
0.85
1.36
g/24h
0.95
542
119
1121
1236
20.74
307.65
11.3
2.5
12.60
10.59
g/l
6.35
1079
1129
1230
723
46.58
307.65
21.6
1.7
111.55
35.93
mg/l
5.98
1155
619
855
751
19.91
307.65
16.7
1.7
6.92
0.69
g/l
45.10
706
632
1250
2446
13.06
307.65
12.6
3.8
226.76
248.90
u/l
4.51
1229
2300
953
2015
8.50
307.65
4.4
2.5
60.97
68.70
e9/l
8.49
755
1502
861
808
18.69
307.65
17.0
1.6
2.54
3.01
g/l
23.16
846
717
453
585
9.86
307.65
21.8
1.6
0.00
0.00
g/l
-0.00
443
547
1075
2576
8.33
307.65
4.8
2.4
1.66
1.82
%
5.77
1037
2288
959
988
18.62
307.65
6.3
1.7
0.77
1.59
g/l
6.77
818
900
405
343
14.74
307.65
6.4
6.0
311.83
755.67
iu/ml
0.65
92
54
1292
1795
20.46
307.65
22.1
1.9
67.14
66.22
g/l
2.26
1269
1632
929
865
20.10
307.65
16.3
1.6
3.75
3.75
g/l
0.00
914
774
274
13
246.20
307.65
1.4
1.0
—
—
—
0
0
1050
2873
6.95
307.65
7.8
1.4
3.31
2.66
g/l
2.26
927
1650
607
636
13.57
307.65
17.5
1.6
0.20
0.01
g/l
3.57
496
571
1159
647
44.51
307.65
19.6
1.7
29.51
1.65
ratio
2.96
864
383
929
866
20.07
307.65
16.3
1.6
4.24
4.21
g/l
0.18
913
776
971
2685
6.36
307.65
11.4
5.4
1.08
1.03
mmol/l
4.45
943
2486
751
332
36.80
307.65
1.8
1.6
—
—
—
0
0
1230
4661
5.67
301.01
9.5
2.9
332.24
357.79
umol/l
11.91
1195
4010
146
12
131.73
289.82
3.8
1.1
—
—
—
0
0
369
492
9.07
269.76
2.7
1.6
—
—
—
0
0
134
14
102.92
259.30
9.8
1.4
—
—
—
0
0
180
76
26.06
255.25
8.0
1.3
40.66
39.51
g/l
0.82
180
76
351
487
8.62
247.44
2.6
1.6
—
—
—
0
0
273
282
11.14
241.42
2.4
3.0
200.21
2175.04
u/ml
1.26
14
28
297
346
9.99
240.54
1.3
1.3
82.79
35.10
u/l
3.89
285
296
344
523
7.81
223.12
1.9
1.5
—
—
—
0
0
886
3230
4.27
209.52
6.2
3.2
0.80
0.81
mmol/l
3.29
858
3033
264
336
8.97
198.44
2.8
1.7
—
—
—
0
0
256
326
8.92
192.18
5.0
4.1
1.72
1.56
%
0.20
239
294
441
1050
5.17
178.05
2.3
1.7
1.39
1.55
g/l
2.59
399
912
526
1462
4.60
175.21
2.4
1.7
—
—
—
0
0
183
186
10.78
162.37
3.1
1.7
—
—
—
0
0
861
3574
3.58
158.90
3.6
2.0
—
—
—
0
0
185
199
10.19
157.51
3.1
1.7
—
—
—
0
0
1396
7886
3.92
156.77
17.8
6.2
54.84
58.63
%
22.23
1378
7499
140
99
15.19
155.78
2.0
2.8
32.42
39.58
%
1.71
50
59
1410
8043
3.94
155.38
18.9
6.4
28.56
25.90
%
11.91
1396
7583
769
3006
3.62
155.26
3.1
2.0
28.57
29.86
s
7.58
747
2917
1459
8525
4.09
154.72
19.4
6.0
0.55
0.62
e9/l
20.68
1347
7172
1460
8551
4.08
153.88
19.3
6.0
0.03
0.04
e9/l
40.06
1346
7200
1463
8684
4.00
148.59
19.5
6.1
1.74
1.88
e9/l
1.00
1369
7515
1471
8798
4.00
146.84
20.3
6.3
0.15
0.20
e9/l
14.75
1365
7539
197
252
8.61
146.46
1.4
1.5
141.77
150.22
au/ml
0.32
56
74
1412
8386
3.68
138.67
22.4
5.0
34.19
34.75
g/l
3.04
1379
7844
91
32
29.82
136.69
2.1
1.2
—
—
—
0
0
228
372
6.83
136.37
1.3
1.2
—
—
—
0
0
557
1903
3.73
135.66
10.3
6.6
12.65
10.73
mmol/l
5.71
538
1820
139
123
12.12
135.07
3.4
2.3
10.84
46.44
iu/ml
1.98
27
26
155
161
10.40
135.05
3.2
1.6
—
—
—
0
0
155
161
10.40
135.05
3.2
1.6
—
—
—
0
0
155
161
10.40
135.05
3.2
1.6
—
—
—
0
0
113
70
17.10
134.61
3.7
1.9
—
—
—
0
0
112
69
17.19
133.78
3.6
1.9
—
—
—
0
0
112
69
17.19
133.78
3.6
1.9
—
—
—
0
0
176
219
8.76
133.61
5.2
4.0
56.20
58.80
%
0.66
159
192
751
3136
3.31
132.52
3.6
2.6
2.10
2.26
g/l
13.50
725
2886
681
2706
3.37
130.06
2.8
1.9
—
—
—
0
0
123
95
13.78
129.91
3.5
1.7
—
—
—
0
0
123
95
13.78
129.91
3.5
1.7
—
—
—
0
0
123
95
13.78
129.91
3.5
1.7
—
—
—
0
0
123
95
13.78
129.91
3.5
1.7
—
—
—
0
0
138
129
11.46
129.28
1.1
1.0
—
—
—
0
0
708
2931
3.26
125.58
3.7
2.6
24.30
21.87
%
5.10
688
2719
1493
9500
3.69
124.38
39.2
7.2
1.21
1.21
mmol/l
0.16
1400
8167
130
119
11.65
123.43
1.2
1.2
—
—
—
0
0
766
3352
3.16
123.10
3.7
2.6
12.87
12.22
umol/l
1.89
739
3113
299
690
4.96
122.82
1.7
1.3
—
—
—
0
0
158
191
8.93
122.59
4.3
2.6
—
—
—
0
0
1497
9590
3.67
122.25
44.3
9.4
3.15
4.29
e9/l
93.19
1396
8239
226
409
6.14
121.60
1.8
1.4
—
—
—
0
0
1387
8584
3.29
117.81
31.1
6.5
1.21
1.21
mmol/l
2.40
1360
7887
1456
9386
3.38
112.88
20.6
6.8
10.29
12.22
umol/l
14.23
1440
8959
202
356
6.23
111.44
1.6
1.4
—
—
—
0
0
608
2527
3.07
104.03
2.9
1.9
—
—
—
0
0
123
139
9.39
100.33
2.9
1.9
1065.86
1103.30
e6/l
0.13
111
124
107
112
10.07
92.32
1.5
1.3
—
—
—
0
0
107
112
10.07
92.32
1.5
1.3
—
—
—
0
0
183
354
5.61
91.16
1.9
1.4
—
—
—
0
0
101
103
10.30
88.76
3.0
1.7
—
—
—
0
0
148
240
6.60
88.31
1.8
1.6
—
—
—
0
0
90
80
11.76
86.83
2.2
5.8
—
43.73
—
0
15
148
248
6.39
85.48
1.8
1.6
—
—
—
0
0
207
493
4.59
80.65
3.4
2.3
3.70
3.61
g/l
0.32
202
469
408
1549
3.08
79.48
4.5
3.8
94.13
96.05
ng/l
0.13
360
1325
156
296
5.65
79.15
1.8
1.4
—
—
—
0
0
109
146
7.86
77.30
1.2
1.3
—
—
—
0
0
87
93
9.76
73.79
3.5
3.8
1.34
1.11
%
0.52
87
93
89
101
9.20
72.16
2.3
2.0
18.33
15.73
%
0.90
84
96
1035
6429
2.34
70.81
9.2
3.5
2.32
2.35
mmol/l
6.86
987
5736
136
253
5.71
70.37
1.5
1.2
209.13
284.09
u/ml
1.31
82
136
82
87
9.81
69.91
2.2
1.4
—
—
—
0
0
82
87
9.81
69.91
2.2
1.4
—
—
—
0
0
285
940
3.39
69.66
2.5
1.8
2.09
2.25
ug/l
0.08
260
825
86
102
8.78
67.34
2.2
2.0
—
—
—
0
0
869
5121
2.29
65.92
2.5
2.4
2.79
2.93
mg/l
0.92
765
4376
81
95
8.86
63.97
3.7
2.3
230.25
205.71
e6/l
0.30
72
84
93
129
7.53
63.89
2.1
1.4
—
—
—
0
0
92
129
7.44
62.60
2.1
1.4
—
—
—
0
0
83
104
8.30
62.15
1.2
1.3
86.27
79.67
—
15
6
447
2029
2.57
60.35
6.8
2.7
6.00
9.30
umol/l
5.29
404
1817
78
94
8.61
60.27
3.3
2.1
635.69
552.33
e6/l
0.29
65
78
1097
7293
2.20
59.68
4.4
3.0
298.70
153.14
ug/l
14.98
1052
6666
184
516
3.84
57.11
2.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
224
719
3.40
56.70
3.2
2.8
0.32
0.36
iu/ml
0.89
125
393
998
6532
2.11
54.78
5.0
3.4
1981.82
1646.39
ng/l
1.22
929
5735
95
160
6.20
54.35
1.4
1.6
—
—
—
0
0
1407
10577
2.28
53.10
16.2
5.3
6.65
6.87
mmol/l
4.49
1380
10127
1154
8033
2.12
53.08
7.1
2.9
—
—
estimate
—
0
0
126
288
4.62
51.27
6.0
6.1
11.12
12.52
mg/l
2.60
117
268
329
1407
2.62
49.37
2.4
1.7
—
—
—
0
0
743
4482
2.08
49.28
6.8
2.5
—
—
—
0
0
432
2106
2.36
48.78
6.7
3.5
1.19
1.88
mmol/l
3.11
377
1801
110
235
4.91
48.55
2.4
1.5
—
—
—
0
0
632
3611
2.13
48.23
2.4
1.7
1.54
1.54
mg/l
0.00
536
2855
109
233
4.90
48.07
2.4
1.4
—
—
—
0
0
109
234
4.88
47.83
2.4
1.4
—
—
—
0
0
439
2175
2.33
47.63
6.7
3.5
5.65
5.84
kpa
3.58
433
2116
106
227
4.89
46.64
2.5
1.5
—
—
—
0
0
106
227
4.89
46.64
2.5
1.5
—
—
—
0
0
106
229
4.84
46.15
2.5
1.5
—
—
—
0
0
167
529
3.37
42.86
4.1
3.3
1.86
1.74
mg/l
0.82
154
470
310
1380
2.49
42.34
5.7
3.9
4.79
5.18
kpa
12.65
294
1323
911
6145
1.93
41.97
4.7
3.7
35.47
91.51
e6/l
2.45
768
4820
276
1173
2.58
41.52
5.5
3.8
1.00
2.07
mmol/l
4.52
199
872
336
1568
2.39
41.29
2.4
2.2
392.87
381.40
nmol/l
0.43
325
1431
254
1044
2.65
40.86
1.7
1.5
—
—
—
0
0
37
26
14.49
40.84
1.3
1.1
—
—
—
0
0
281
1239
2.49
38.98
7.1
3.5
23.60
24.15
mmol/l
1.90
281
1221
209
796
2.83
38.91
4.5
2.0
—
—
—
0
0
711
4509
1.92
38.60
7.7
4.4
87.05
84.62
%
1.85
698
4416
863
5837
1.88
38.32
2.2
1.8
18.52
19.98
nmol/l
2.30
812
4845
78
155
5.21
37.38
1.8
1.6
—
—
—
0
0
74
141
5.42
37.16
1.4
1.3
10.50
7.20
g/l
1.50
50
103
1210
9168
1.88
36.88
17.5
19.0
1.29
1.34
inr
1.27
1047
7712
1008
7238
1.84
36.25
34.2
12.7
0.01
0.00
e9/l
0.80
864
5858
955
6745
1.84
36.24
5.6
4.3
73.22
113.27
e6/l
1.20
778
4980
680
4362
1.87
34.80
3.4
2.8
5.36
4.91
e6/l
0.40
643
4001
789
5319
1.83
34.28
4.7
3.6
0.47
0.47
e6/l
0.03
649
4032
309
1517
2.24
33.21
21.5
4.0
1.22
1.22
mmol/l
1.13
302
1300
49
71
7.06
32.30
1.7
2.5
3456.86
36882.46
u/ml
—
7
13
583
3656
1.86
31.41
1.9
1.8
1145.21
1152.21
nmol/l
0.06
474
2744
133
449
3.11
30.59
1.8
1.5
0.24
0.24
g/l
0.01
123
430
54
92
6.01
30.49
1.2
1.2
—
—
—
0
0
135
466
3.04
29.87
1.8
1.5
1.14
1.17
g/l
0.66
128
449
178
738
2.56
27.78
6.1
4.1
24.13
24.94
mmol/l
3.37
165
681
1526
12973
1.90
26.71
33.3
8.6
79.44
81.73
u/l
1.07
1513
12275
173
737
2.48
25.46
3.1
1.9
—
—
—
0
0
81
227
3.68
24.99
1.2
1.3
196.31
211.07
miu/ml
0.11
24
78
1008
7741
1.65
24.40
3.6
2.4
—
—
—
0
0
57
128
4.56
23.67
1.6
1.4
—
—
—
0
0
769
5586
1.63
22.74
2.9
2.7
58.93
76.81
u/l
0.64
735
5152
37
58
6.49
22.67
1.1
1.2
—
—
—
0
0
114
419
2.83
22.50
1.6
1.3
—
—
—
0
0
114
419
2.83
22.50
1.6
1.3
—
—
—
0
0
51
109
4.78
22.49
1.7
1.5
—
—
—
0
0
948
7262
1.61
22.45
6.0
4.4
45.63
70.89
ng/l
1.15
842
5756
52
114
4.66
22.25
1.7
1.5
—
—
—
0
0
509
3364
1.70
21.47
4.1
3.2
1.12
1.17
e6/l
0.09
301
1879
315
1812
1.89
21.27
5.5
2.9
4.65
4.45
kpa
0.80
310
1760
365
2208
1.81
20.95
7.8
7.6
95.12
95.39
%
0.32
350
2134
1342
11291
1.65
20.74
6.6
5.3
1393.25
1788.15
e6/l
0.13
24
191
578
3982
1.65
20.66
6.2
3.1
2.49
2.46
mmol/l
4.05
538
3574
396
2466
1.77
20.56
8.0
7.4
4.89
5.09
kpa
2.87
378
2367
393
2448
1.76
20.37
7.7
7.4
0.66
0.91
mmol/l
0.51
314
2006
395
2467
1.76
20.27
8.0
7.4
11.70
11.89
kpa
0.33
377
2373
157
709
2.32
20.22
1.3
1.9
34.63
38.82
u/l
1.46
143
612
470
3103
1.68
19.64
4.4
3.4
2.16
2.03
e6/l
0.14
259
1613
1417
12178
1.65
19.17
9.2
4.6
33.20
13.94
mm/h
86.86
1373
11287
40
80
5.09
19.06
1.9
2.4
2265.55
1397.75
u/ml
0.37
40
80
1057
8495
1.55
19.03
2.8
2.3
89.86
94.35
pmol/l
2.57
743
4517
315
1879
1.81
18.77
8.0
7.3
1.26
1.38
mmol/l
1.77
309
1846
1367
15312
0.62
18.46
5.5
6.4
2.45
2.53
mmol/l
2.72
1272
13940
162
770
2.21
18.45
2.7
2.7
—
—
—
0
0
461
6520
0.61
18.01
2.0
2.0
1.62
1.31
mmol/l
2.71
407
5334
110
447
2.55
17.84
1.3
2.1
15.29
12.55
mg/l
1.63
103
407
330
2032
1.76
17.57
8.9
8.0
108.14
120.69
g/l
24.46
321
1983
955
7631
1.51
16.77
3.0
2.4
81.67
79.24
nmol/l
1.79
900
6705
236
1335
1.88
16.57
5.3
2.9
112.00
127.77
g/l
20.64
227
1295
1322
14836
0.64
16.50
7.2
7.4
40.20
40.36
mmol/mol
0.27
1239
13643
536
3809
1.57
16.10
6.2
4.3
109.73
644.73
ng/l
1.67
474
3279
1069
8797
1.49
15.90
4.9
4.3
0.00
0.00
estimate
-0.00
257
1903
25
38
6.65
15.76
1.6
1.4
112.40
126.00
titre
—
5
9
33
66
5.07
15.75
1.1
1.5
—
—
—
0
0
704
5354
1.50
15.28
6.0
3.2
34.99
35.90
u/l
0.14
683
5046
150
745
2.10
15.25
4.1
3.1
23.75
25.02
mmol/l
3.40
144
734
29
54
5.44
14.96
1.1
1.1
939.66
1574.96
miu/ml
1.77
29
54
1334
14866
0.65
14.89
4.9
5.4
1.35
1.44
mmol/l
11.04
1238
13485
1079
8974
1.47
14.67
4.9
4.3
0.01
0.18
estimate
0.51
248
1828
1073
8920
1.47
14.59
4.9
4.3
16.70
2.56
estimate
0.83
269
1951
1349
14983
0.65
14.56
5.0
5.5
4.30
4.43
mmol/l
4.53
1257
13705
179
983
1.91
13.70
5.3
3.2
24.62
25.23
mmol/l
1.51
174
948
1369
15081
0.67
12.97
6.0
5.8
6.14
6.09
mmol/l
0.67
1260
13563
91
403
2.32
12.29
4.2
5.3
2.45
2.70
mmol/l
0.44
65
286
22
38
5.85
12.27
1.5
1.4
—
—
—
0
0
153
859
1.85
10.93
7.7
5.0
0.87
0.87
%
0.01
146
809
163
945
1.79
10.49
7.4
4.8
1.61
1.56
%
0.27
156
891
223
1420
1.65
10.21
5.0
3.0
52.65
61.23
ml/min/173m2
3.32
133
631
42
139
3.07
10.11
1.1
1.2
95.95
101.86
pmol/l
0.19
42
139
102
515
2.04
9.97
4.4
3.6
2.75
1.71
index
0.71
64
271
191
1188
1.68
9.56
10.3
9.8
14.16
15.83
%
12.72
183
1144
30
83
3.66
9.55
1.2
1.1
—
—
—
0
0
51
195
2.66
9.46
1.5
1.4
—
—
—
0
0
135
766
1.82
9.33
2.8
2.2
625.83
517.91
ug/l
0.19
128
725
568
4468
1.39
9.17
3.8
3.3
0.06
0.04
0.11
18
131
97
496
2.01
9.17
3.7
2.2
115.39
127.75
g/l
5.54
79
391
20
42
4.80
9.07
1.0
1.0
—
—
—
0
0
18
21
8.64
8.79
10.7
10.8
4.63
5.21
mmol/l
0.72
18
21
201
1302
1.61
8.57
9.2
9.1
23.84
24.24
mmol/l
0.83
192
1275
1310
14281
0.73
8.51
4.7
4.6
1.38
1.27
mmol/l
2.57
1207
12810
304
2166
1.48
8.40
2.9
4.2
5.30
22.47
ug/l
3.08
239
1798
68
316
2.19
8.28
1.3
1.3
—
—
—
0
0
198
1292
1.59
8.18
7.6
6.4
24.03
24.38
mmol/l
0.59
187
1237
71
345
2.10
7.74
1.5
1.5
29.77
30.98
g/l
0.27
62
312
26
76
3.45
7.68
1.2
1.2
—
—
—
0
0
282
2020
1.47
7.55
5.1
3.7
—
—
—
0
0
111
636
1.79
7.47
1.7
1.7
3.19
7.44
iu/ml
2.85
21
154
86
464
1.89
7.02
1.3
1.5
—
—
—
0
0
16
24
6.71
6.81
1.8
1.9
—
—
—
0
0
83
456
1.86
6.44
1.5
1.6
—
—
—
0
0
94
538
1.79
6.39
1.4
1.5
227.23
268.16
ug/g
1.24
54
331
9
5
18.08
6.26
1.7
3.6
—
—
—
0
0
55
264
2.12
6.25
4.0
3.9
88.36
34.80
u/ml
0.62
55
259
124
773
1.65
6.20
2.4
3.4
506.10
6326.41
u/ml
0.95
100
671
61
306
2.03
6.18
1.4
1.4
1177.31
4419.31
e6/l
0.59
42
215
697
5926
1.28
5.98
2.4
2.3
153.06
226.08
u/l
3.15
667
5593
81
453
1.82
5.96
2.0
2.7
28.84
34.11
umol/l
1.48
65
397
237
1718
1.43
5.92
2.9
2.5
45.36
38.72
u/l
0.39
197
1430
9
6
15.06
5.90
1.1
1.2
296.89
190.67
nmol/l
—
9
6
86
492
1.78
5.88
1.4
1.5
0.21
13.62
iu/ml
0.56
17
99
132
850
1.59
5.80
4.4
3.4
4.40
4.35
pmol/l
0.22
123
745
242
1772
1.42
5.72
4.1
3.1
276.07
233.54
ng/l
0.67
224
1634
10
10
10.05
5.53
2.0
4.7
—
—
—
0
0
8
5
16.06
5.41
1.1
2.2
—
—
—
0
0
92
551
1.70
5.38
1.8
1.7
—
—
—
0
0
235
1731
1.41
5.37
2.4
2.2
174.91
158.69
ug/g
0.19
194
1384
24
84
2.88
5.36
1.3
1.0
—
—
—
0
0
77
440
1.78
5.31
1.2
1.1
—
—
—
0
0
15
30
5.03
5.25
1.1
1.1
—
—
—
0
0
76
437
1.77
5.14
1.2
1.2
—
—
—
0
0
252
1892
1.38
5.14
2.4
2.2
0.19
0.20
g/l
1.03
235
1755
40
185
2.19
5.05
1.1
1.2
1.50
4.11
u/ml
1.17
14
63
149
1020
1.50
5.01
2.2
2.5
16.46
19.53
au/ml
—
5
70
39
180
2.19
4.95
1.5
1.3
10.81
12.07
u/l
0.24
32
167
39
181
2.18
4.89
1.2
1.2
3.00
7.51
u/ml
1.08
14
93
8
7
11.47
4.78
1.6
1.1
—
—
—
0
0
1571
16392
0.76
4.74
85.4
29.8
117.92
132.99
g/l
208.98
1558
16163
1571
16390
0.76
4.71
84.8
29.6
6.27
6.91
e9/l
4.93
1547
15936
1571
16389
0.76
4.70
85.5
30.1
35.68
39.74
%
157.37
1557
16148
1571
16389
0.76
4.70
84.7
29.5
3.82
4.40
e12/l
221.26
1546
15937
1571
16388
0.76
4.69
84.9
29.5
199.42
241.31
e9/l
83.15
1548
15996
1571
16386
0.76
4.66
84.6
29.5
95.33
91.81
fl
111.89
1557
16154
598
5117
1.25
4.59
4.9
4.3
0.01
0.00
estimate
0.34
209
1728
8
8
10.04
4.52
1.4
1.1
—
—
—
0
0
133
915
1.49
4.39
1.2
1.4
69.05
55.72
au/ml
—
6
72
70
413
1.72
4.38
9.3
6.7
105.30
105.51
mmol/l
0.11
63
369
46
238
1.96
4.37
5.6
5.7
6.84
7.47
mmol/l
0.66
36
207
26
108
2.43
4.23
1.5
1.2
41.42
23.82
u/l
0.97
26
90
45
234
1.95
4.22
2.8
3.8
—
—
—
0
0
25
104
2.42
4.06
1.3
1.6
16.44
15.22
umol/l
0.26
25
94
223
1708
1.35
4.02
1.4
1.4
—
—
—
0
0
7
7
10.03
4.01
1.6
1.1
—
—
—
0
0
14
36
3.91
3.99
1.6
2.5
275.29
191.77
%
0.73
14
30
10
18
5.58
3.97
1.2
1.1
—
—
—
0
0
50
276
1.83
3.94
1.5
1.6
15.52
28.68
ug/l
1.90
50
270
26
114
2.30
3.78
1.5
1.2
129.88
92.26
u/l
0.65
26
97
1569
16289
0.79
3.67
73.8
26.3
106.65
83.31
umol/l
24.43
1554
16070
736
6553
1.20
3.63
5.1
4.3
0.02
0.05
estimate
0.65
222
1557
48
270
1.80
3.59
1.4
1.4
71803.71
85768.33
e6/l
0.12
24
157
36
659
0.54
3.47
1.4
1.9
3.68
3.45
mmol/l
0.42
30
496
1364
14322
0.83
3.22
5.8
5.4
2.12
2.03
mu/l
1.37
1295
12978
12
34
3.55
3.19
1.9
1.2
24.86
920.67
u/l
—
7
24
7
11
6.38
3.18
1.4
1.1
—
—
—
0
0
7
11
6.38
3.18
1.0
1.0
—
—
—
0
0
86
584
1.50
3.11
1.2
1.3
—
—
—
0
0
68
439
1.57
3.09
6.9
3.4
7.39
7.59
mmol/l
0.26
68
426
1548
16040
0.81
3.08
42.7
13.3
25.90
25.33
u/l
0.53
1531
15490
13
41
3.19
3.05
1.3
1.2
—
—
—
0
0
35
189
1.87
3.02
4.2
3.4
13.59
10.59
index
1.14
27
102
382
3243
1.22
3.02
1.3
1.3
1.20
1.46
u/ml
0.34
56
838
514
4496
1.20
2.97
4.5
3.8
0.00
0.04
estimate
1.09
211
1470
21
95
2.22
2.90
1.0
1.1
—
—
—
0
0
131
981
1.36
2.79
4.4
3.8
1.02
1.02
ratio
0.57
121
896
5
6
8.35
2.75
1.4
1.0
—
—
—
0
0
6
10
6.02
2.70
1.3
1.0
—
—
—
0
0
6
10
6.02
2.70
1.0
1.0
—
—
—
0
0
29
517
0.55
2.62
1.6
1.6
—
—
—
0
0
14
55
2.56
2.61
1.0
1.1
—
—
—
0
0
62
916
0.67
2.58
1.8
2.1
3.89
3.46
ratio
1.22
56
748
16
68
2.36
2.56
4.3
2.4
0.59
0.61
mmol/l
0.43
16
68
12
44
2.74
2.54
1.9
1.1
0.44
2.41
mmol/l
—
7
30
35
203
1.74
2.45
1.3
1.6
70.14
62.21
%
0.64
22
130
362
4172
0.84
2.43
3.0
3.5
0.95
0.79
ug/l
1.30
266
2940
78
549
1.44
2.42
1.2
1.2
0.32
0.91
u/ml
—
5
37
18
83
2.18
2.41
8.6
6.8
1376.98
35.02
ug/l
0.65
13
52
10
250
0.40
2.36
1.4
1.2
1.54
1.54
g/l
—
10
250
7
17
4.13
2.36
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
84
2.15
2.35
1.1
1.2
—
—
—
0
0
11
39
2.83
2.34
1.0
1.1
—
—
—
0
0
9
28
3.22
2.30
1.2
1.2
—
—
—
0
0
12
47
2.56
2.27
1.9
1.1
1.39
1.43
mmol/l
—
7
32
53
350
1.53
2.26
1.4
1.3
13.13
52.78
e6/l
0.91
38
258
15
66
2.28
2.24
1.5
1.1
0.53
0.47
ratio
—
6
39
37
225
1.66
2.22
1.4
1.3
275.69
274.81
mosm/kgh2o
0.06
29
160
35
563
0.61
2.19
1.6
1.6
—
—
—
0
0
53
353
1.52
2.18
1.5
1.4
25.76
549.39
e6/l
0.97
38
275
25
136
1.85
2.18
1.1
1.2
—
—
—
0
0
21
108
1.96
2.15
4.0
3.7
—
—
—
0
0
10
36
2.79
2.13
1.1
1.1
—
—
—
0
0
70
497
1.42
2.11
1.7
1.7
16589.85
14274.18
e6/l
0.23
47
352
52
350
1.50
2.06
1.2
1.3
—
—
—
0
0
23
400
0.57
1.97
1.6
1.7
7.64
4.16
mg/l
0.46
15
322
7
21
3.34
1.96
1.0
1.4
—
—
—
0
0
1564
16061
0.85
1.92
67.1
24.1
3.99
4.00
mmol/l
1.13
1551
15725
17
85
2.01
1.90
1.7
1.5
0.92
2.96
u/field
1.99
12
60
23
128
1.81
1.90
2.2
2.8
43.00
30.74
mg/l
0.70
18
97
40
260
1.55
1.87
2.2
2.4
86.94
171.12
u/ml
0.21
40
255
16
79
2.03
1.85
1.0
1.2
—
—
—
0
0
1563
16039
0.85
1.83
61.6
23.9
138.87
139.61
mmol/l
25.19
1550
15722
24
139
1.74
1.76
1.9
2.4
589.68
652.22
ml
0.45
19
88
1440
14844
0.88
1.69
52.4
19.5
67.52
73.77
ml/min/173m2
20.02
1383
13912
125
1535
0.80
1.62
1.3
1.4
—
—
—
0
0
22
129
1.71
1.57
1.7
1.9
98.60
116.40
ng/l
0.41
22
129
17
92
1.86
1.56
2.3
1.8
208.30
3028.69
u/l
—
8
31
10
44
2.28
1.55
1.2
1.1
—
—
—
0
0
437
3958
1.14
1.54
5.0
4.5
1.02
1.02
kg/l
0.38
331
2672
7
27
2.60
1.51
1.0
1.2
—
—
—
0
0
12
225
0.53
1.40
1.8
1.4
—
—
—
0
0
10
46
2.18
1.40
1.2
1.1
—
—
—
0
0
10
46
2.18
1.40
1.2
1.1
—
—
—
0
0
67
513
1.32
1.36
1.4
1.4
—
—
—
0
0
16
273
0.58
1.36
3.0
1.3
0.79
0.91
g/l
0.96
16
273
10
47
2.13
1.33
1.2
1.1
—
—
—
0
0
115
1389
0.82
1.32
1.5
1.5
—
—
—
0
0
13
69
1.89
1.28
1.0
1.1
—
—
—
0
0
5
18
2.78
1.28
1.4
1.1
—
—
—
0
0
27
178
1.52
1.26
1.3
1.3
—
—
—
0
0
69
540
1.29
1.22
1.5
1.5
55.89
22.49
u/ml
1.03
14
89
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
61
470
1.31
1.21
1.6
1.6
—
—
—
0
0
58
444
1.32
1.21
2.3
3.4
155.08
980.10
u/ml
0.81
53
415
208
1824
1.16
1.19
2.9
2.5
5.73
7.55
ug/l
0.92
182
1607
10
50
2.01
1.16
1.2
1.1
—
—
—
0
0
69
545
1.28
1.15
2.7
3.5
0.77
0.83
nmol/l
0.68
46
445
5
20
2.50
1.15
1.4
1.1
—
—
—
0
0
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
25
167
1.50
1.12
1.1
1.1
—
—
—
0
0
534
5705
0.91
1.07
4.2
5.0
22.80
21.84
%
0.69
285
3030
18
113
1.60
1.05
2.3
2.3
—
—
—
0
0
21
138
1.53
1.03
2.9
2.2
7.74
8.25
mmol/l
0.49
21
138
23
155
1.49
1.01
1.9
2.1
0.62
1.54
u/field
1.57
13
82
1564
15339
1.11
1.01
64.5
19.5
21.83
27.47
mg/l
12.41
1515
13053
13
76
1.72
0.99
1.2
1.0
1.04
1.21
u/l
—
5
39
31
223
1.40
0.98
1.7
1.4
—
—
—
0
0
7
36
1.95
0.97
1.1
3.0
13.76
14.94
ml/dl
—
7
31
9
50
1.80
0.96
1.2
2.1
39.97
176.84
ug/l
—
9
44
1264
12295
1.08
0.92
71.2
24.3
15.01
13.88
%
99.12
1255
12119
429
4006
1.09
0.87
1.8
1.8
425.37
22433779.70
pmol/l
2.58
366
3263
11
64
1.72
0.86
1.0
1.1
—
—
—
0
0
8
47
1.71
0.80
1.0
1.1
—
—
—
0
0
105
909
1.16
0.78
1.4
1.3
75.44
208.40
u/ml
4.84
99
837
1005
9738
1.07
0.75
4.0
3.4
65.34
55.49
u/l
1.55
968
8973
18
125
1.44
0.72
1.1
1.1
—
—
—
0
0
16
109
1.47
0.71
1.4
1.2
—
—
—
0
0
16
109
1.47
0.71
1.4
1.2
—
—
—
0
0
14
205
0.68
0.70
2.5
1.7
—
—
—
0
0
16
110
1.46
0.68
1.0
1.1
—
—
—
0
0
19
137
1.39
0.64
1.1
1.1
—
—
—
0
0
16
112
1.43
0.63
1.0
1.2
—
—
—
0
0
13
88
1.48
0.60
1.1
1.3
—
—
—
0
0
622
6473
0.94
0.60
3.8
3.5
6.82
7.23
mmol/l
1.81
557
5368
289
2702
1.08
0.59
1.3
1.3
27.42
39.19
iu/ml
0.77
84
858
16
115
1.39
0.56
1.0
1.1
—
—
—
0
0
16
115
1.39
0.56
1.0
1.1
—
—
—
0
0
23
176
1.31
0.56
1.1
1.1
—
51.80
—
0
15
11
73
1.51
0.56
1.4
1.2
—
—
—
0
0
17
124
1.37
0.55
1.0
1.1
—
—
—
0
0
10
65
1.54
0.55
1.3
1.0
—
—
—
0
0
30
240
1.25
0.54
1.2
1.1
—
4.86
—
0
7
25
315
0.79
0.52
1.3
1.4
—
—
—
0
0
12
169
0.71
0.52
2.3
1.7
—
—
—
0
0
6
40
1.50
0.51
1.3
1.3
0.32
0.29
g/l
—
6
30
16
118
1.36
0.50
1.0
1.5
0.77
0.98
promille
0.21
11
95
11
77
1.43
0.45
1.1
1.7
76.20
85.74
umol/l
—
5
50
11
77
1.43
0.45
1.3
1.3
122.83
158.09
pmol/l
0.41
11
77
5
85
0.59
0.45
3.8
3.8
14.10
13.41
%
—
5
85
23
183
1.26
0.45
1.5
1.3
18347.08
86246.52
e6/l
1.03
13
124
132
1436
0.91
0.45
1.7
1.7
1.47
1.61
%
1.99
111
1192
51
442
1.16
0.43
1.3
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
0.11
—
0
7
46
398
1.16
0.41
4.1
3.8
25.44
27.60
mg/l
0.24
31
276
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
17
0.00
0.40
0.0
1.2
—
4158.00
—
0
10
89
807
1.11
0.40
1.1
1.2
107.73
135.80
u/ml
0.31
29
283
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
15
115
1.31
0.39
1.5
1.2
0.03
1.12
u/ml
—
10
61
9
66
1.37
0.38
1.9
2.9
10.73
10.12
kpa
—
9
66
9
66
1.37
0.38
1.9
2.9
5.10
4.79
kpa
—
9
66
634
6514
0.96
0.36
4.5
4.2
26.47
8.43
mg/mmol
4.58
470
4096
6
44
1.36
0.34
2.0
1.8
55.50
852.52
nmol/24h
—
6
44
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
38
334
1.14
0.30
1.1
1.4
1.01
0.85
nmol/l
0.69
33
266
24
203
1.18
0.30
1.4
1.3
322.62
298.13
pmol/l
0.13
18
168
32
278
1.15
0.29
1.9
1.3
14.28
9.85
u/l
0.65
24
219
12
94
1.28
0.28
2.2
1.9
19.91
17.27
nmol/l
0.41
12
84
1204
11902
1.03
0.26
4.7
4.3
14.99
15.07
pmol/l
0.54
1136
10673
50
454
1.10
0.25
1.3
1.2
71.57
32.13
u/ml
—
6
25
30
265
1.13
0.23
2.1
1.3
26.28
32.12
iu/l
0.44
23
223
210
2183
0.96
0.23
12.7
7.9
—
—
—
0
0
48
438
1.10
0.22
1.4
1.2
1.42
7.28
u/ml
—
6
68
32
285
1.12
0.22
1.1
1.1
—
—
—
0
0
19
163
1.17
0.21
1.5
1.4
26.75
28.64
%
0.09
12
100
0
11
0.00
0.21
0.0
1.2
—
0.18
—
0
6
0
11
0.00
0.21
0.0
1.4
—
6.25
—
0
11
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
1.15
—
0
6
12
98
1.23
0.21
2.2
2.0
—
—
—
0
0
20
229
0.87
0.20
2.1
1.3
0.88
8.54
nmol/l
0.48
20
216
6
50
1.20
0.19
2.8
3.1
4.17
568.28
ug/l
—
6
50
40
366
1.09
0.19
1.8
1.9
3.37
20.32
iu/l
0.52
17
142
28
252
1.11
0.17
1.8
2.4
33.78
20.85
mg/l
—
9
87
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
48
448
1.07
0.15
2.4
2.3
80.77
98.22
ug/min
0.25
34
269
217
2215
0.98
0.10
4.3
5.4
33.17
33.17
%
0.00
161
1406
18
164
1.10
0.09
1.7
1.3
—
—
—
0
0
5
46
1.09
0.09
1.2
1.0
151.80
254.69
pmol/l
—
5
32
5
48
1.04
0.09
3.0
1.3
10.94
9.36
ug/l
—
5
48
5
64
0.78
0.08
4.0
9.0
72.40
70.71
%
—
5
51
6
70
0.86
0.07
1.0
1.3
33.17
30.21
umol/l
—
6
63
13
119
1.09
0.06
1.0
1.1
0.04
1.04
u/ml
—
6
63
253
2558
0.99
0.05
1.3
1.3
6.62
13.76
u/ml
1.10
65
910
20
212
0.94
0.05
1.3
1.0
—
—
—
0
0
54
550
0.98
0.02
1.5
1.6
0.40
0.35
mg/l
0.20
22
243
16
168
0.95
0.02
1.1
1.1
0.16
1.17
u/ml
—
9
95
709
7072
1.00
0.02
5.2
6.1
2.91
3.91
ug/l
0.80
639
6325
11
103
1.07
0.02
1.6
1.6
81.45
92.10
umol/l
0.71
11
103
61
618
0.99
0.01
1.1
1.1
—
—
—
0
0
27
271
1.00
0.00
1.3
1.5
311.62
350.22
pmol/l
0.08
27
266
139
1392
1.00
0.00
2.4
2.3
12.54
12.92
nmol/l
0.19
117
1231
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.4
—
74.80
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
1484.17
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
1.10
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.78
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
0.01
—
0
5
0
9
0.00
-0.00
0.0
1.3
—
2.67
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
1.00
—
0
5
8
89
0.90
-0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MULTIPLE_MYELOMA_PLASMA_CELL – Multiple myeloma and malignant plasma cell neoplasms
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).